Form 4: Monopar Therapeutics Insider Sells Shares
Insider Transaction (Form 4)
Patrice Rioux, Acting Chief Medical Officer of Monopar Therapeutics, sold 1 shares of common stock on August 26, 2026 for $111.26 per share.
Summary
- Option exercise/conversion: acquired 1,380 Common Stock at $0.01 ($7) on August 26, 2026; holds 5,066 after (Direct).
- Open-market sale: disposed of 1 Common Stock at $111.26 ($111) on August 26, 2026; holds 5,065 after (Direct).
- Option exercise/conversion: acquired 1,380 Stock Option on August 26, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $111 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Patrice Rioux — Other (Acting Chief Medical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Option exercise/conversion | Common Stock | 1,380 | $0 | $7 | 5,066 |
| 2026-08-26 | Open-market sale | Common Stock | 1 | $111 | $111 | 5,065 |
| 2026-08-26 | Option exercise/conversion | Stock Option | 1,380 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Option exercise/conversion (1,380 shares) |
| 2026-08-26 | Open-market sale (1 shares) |
| 2026-08-26 | Option exercise/conversion (1,380 shares) |
Keywords
insider transaction, Form 4, MNPR, Monopar Therapeutics, bearish, Patrice Rioux
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.